4,6-dimethyl-2-(4-nitrobenzyloxycarbonylthio)pyrimidine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4,6-dimethyl-2-(4-nitrobenzyloxycarbonylthio)pyrimidine
• 英文别名: 4,6-dimethyl-2-(p-nitrobenzyloxycarbonylthio)pyrimidine；2-(p-nitrobenzyloxycarbonyl)thio-4,6-dimethylpyrimidine；S-p-nitrobenzyloxycarbonyl-4,6-dimethyl-2-mercaptopyrimidine；(4-nitrophenyl)methyl (4,6-dimethylpyrimidin-2-yl)sulfanylformate
• 化学式: C₁₄H₁₃N₃O₄S
• 分子量: 319.341
• InChiKey: UGFJIHBTZKEQPF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  123
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  4,6-dimethyl-2-(4-nitrobenzyloxycarbonylthio)pyrimidine 以 1,4-二氧六环 、 水 、 乙酸乙酯 为溶剂， 生成 (2S,4R)-N-tert-butoxycarbonyl-4-tert-butyldimethylsiloxy-2-[2-carbamoyl-1-(p-nitrobenzyloxycarbonylaminomethyl)ethyl]pyrrolidine
  参考文献：
  名称：

  Aminoalkylpyrrolidinylthiocarbapenem derivatives

  摘要：

  根据您的要求，以下是化合物的翻译结果： 一种具有以下公式的化合物：##STR1## 其中R.sup.1是氢原子或甲基，R.sup.2是氢原子或负电荷，R.sup.3是氢原子、卤素原子、羟基、低级烷氧基、低级烷氧酰基、氨基、N-低级烷基氨基、N,N-二低级烷基氨基、低级烷氧酰氨基、芳氧酰氨基、(低级烷基亚磺酰基)氨基、磺酰胺氨基、氰基、硝基、--COOR.sup.4基团(其中R.sup.4是氢原子或低级烷基)或--CON(R.sup.5)R.sup.6基团(其中R.sup.5和R.sup.6可以是相同的或不同的，是氢原子或低级烷基，或者R.sup.5和R.sup.6与相邻的氮原子共同形成一个杂环组，选自包括氮杂环丙基、氮杂环丁基、吡咯烷基、哌啶基、哌嗪基、4-低级烷基哌嗪基和吗啡啉基的组中)，A是线性的或分支的低级亚烷基，X是--N(R.sup.7)R.sup.8基团(其中R.sup.7和R.sup.8可以是相同的或不同的，是氢原子或低级烷基)或--N.sup.+ (R.sup.9)(R.sup.10)R.sup.11基团(其中R.sup.9、R.sup.10和R.sup.11可以是相同的或不同的，是低级烷基)，前提是当A是线性的低级亚烷基时，R.sup.3不是氢原子；或者其药物可接受的盐或酯。

  公开号：

  US05550121A1

文献信息

• 1.BETA.-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems; 1. Synthesis and Antibacterial Activity of B0-2502A and lts Related Compoundsf.
  作者：NORIKAZU OHTAKE、KOJI YAMADA、EIICHI MANO、OSAMU OKAMOTO、RYOSUKE USHIJIMA、SUSUMU NAKAGAWA

  DOI：10.7164/antibiotics.50.567

  日期：——

  The synthesis and biological activity of (1R,5S,6S)-2-[(3S,5S)-5-substituted pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methyl-1-ca rbapen-2-em-3- carboxylic acid, in which lactams and cyclic amines are introduced as substituents, are described. They showed potent antibacterial activity against Gram-positive and Gram-negative bacteria including P. aeruginosa. Among them, BO-2502A (4h-1) was selected

  （1R，5S，6S）-2-[（3S，5S）-5-取代的吡咯烷-3-基硫基] -6-[[（R）-1-羟乙基] -1-甲基-1）的合成和生物活性描述了其中引入内酰胺和环状胺作为取代基的-ca rbapen-2-em-3-羧酸。他们显示出对革兰氏阳性和革兰氏阴性细菌（包括铜绿假单胞菌）的有效抗菌活性。其中，选择了BO-2502A（4h-1）进行进一步评估。
• 2-(substituted pyrrolidinylthio)carbapenem derivatives
  申请人：Banyu Pharmaceutical Co., Ltd.

  公开号：US05374720A1

  公开（公告）日：1994-12-20

  A compound of the formula: ##STR1## wherein R is a hydrogen atom or a methyl group, R.sup.1 is a hydrogen atom or a negative charge, each of R.sup.2 and R.sup.3 which may be the same or different, is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a formimidoyl group, an acetoimidoyl group, --COOR.sup.4, --CON(R.sup.5)R.sup.6, --N(R.sup.5)R.sup.6, --CH.sub.2 COOR.sup.4, --CH.sub.2 N(R.sup.5)R.sup.6 or --CH.sub.2 CON(R.sup.5)R.sup.6 (wherein R.sup.4 is a hydrogen atom or a lower alkyl group, each of R.sup.5 and R.sup.6 which may be the same or different, is a hydrogen atom or a lower alkyl group, or R.sup.5 and R.sup.6 form together with the adjacent nitrogen atom a heterocyclic group selected from the group consisting of an aziridinyl group, an azetidinyl group, a pyrrolidinyl group and a piperidyl group), A is .dbd.NR.sup.7, .dbd.N.sup.+ (R.sup.7)R.sup.8, wherein each of R.sup.7 and R.sup.8 which may be the same or different, is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a formimidoyl group, an acetoimidoyl group, --COOR.sup.4, --CON(R.sup.5)R.sup.6, --N(R.sup.5)R.sup.6, --CH.sub.2 COOR.sup.4, --CH.sub.2 N(R.sup.5)R.sup.6 or --CH.sub.2 CON(R.sup.5)R.sup.6 (wherein R.sup.4, R.sup.5 and R.sup.6 are as defined above), p is an integer of from 0 to 3, and q is an integer of from 1 to 3; or a pharmaceutically acceptable salt or ester thereof.

  该化合物的公式为：##STR1##，其中R是氢原子或甲基基团，R.sup.1是氢原子或负电荷，R.sup.2和R.sup.3可以是相同的或不同的，是氢原子、低级烷基团、羟基低级烷基团、甲酰亚胺基团、乙酰亚胺基团、--COOR.sup.4、--CON(R.sup.5)R.sup.6、--N(R.sup.5)R.sup.6、--CH.sub.2 COOR.sup.4、--CH.sub.2 N(R.sup.5)R.sup.6或--CH.sub.2 CON(R.sup.5)R.sup.6（其中R.sup.4是氢原子或低级烷基团，R.sup.5和R.sup.6可以是相同的或不同的，是氢原子或低级烷基团，或者R.sup.5和R.sup.6与相邻的氮原子共同形成一个杂环组，选自包括氮环丙烷基团、氮环丁烷基团、吡咯烷基团和哌啶基团在内的组中），A是.dbd.NR.sup.7，.dbd.N.sup.+ (R.sup.7)R.sup.8，其中R.sup.7和R.sup.8可以是相同的或不同的，是氢原子、低级烷基团、羟基低级烷基团、甲酰亚胺基团、乙酰亚胺基团、--COOR.sup.4、--CON(R.sup.5)R.sup.6、--N(R.sup.5)R.sup.6、--CH.sub.2 COOR.sup.4、--CH.sub.2 N(R.sup.5)R.sup.6或--CH.sub.2 CON(R.sup.5)R.sup.6（其中R.sup.4、R.sup.5和R.sup.6如上所述定义），p是从0到3的整数，q是从1到3的整数；或其药用可接受的盐或酯。
• Antibacterial .beta.-lactam compounds
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：US04742052A1

  公开（公告）日：1988-05-03

  Novel .beta.-lactam compounds classified into penem compounds, a process for preparing the same and use of such .beta.-lactam compounds are disclosed. These .beta.-lactam compounds exhibit excellent antimicrobial activities useful as pharmaceuticals or they are important intermediates for the synthesis of compounds having antimicrobial activities.

  本发明公开了分类为单环β-内酰胺化合物的戊二烯化合物，其制备方法以及此类β-内酰胺化合物的用途。这些β-内酰胺化合物展现出卓越的抗菌活性，可用作药物，或者它们是合成具有抗菌活性的化合物的重要中间体。
• Carbapenem compounds and production thereof
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：US04962103A1

  公开（公告）日：1990-10-09

  A compound of the formula: ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl group, R.sub.2 is a hydrogen atom or a conventional protecting group for a carboxyl group, R.sub.0 is a hydrogen atom or a conventional protecting group for a hydroxyl group, X is a protected or unprotected amino group, a carboxyl group, a lower alkoxycarbonyl group, an ar(lower)alkyloxycarbonyl group, a cyano group, a hydroxyl group, a lower alkyloxy group, a lower alkylthio group, a lower alkylsulfonyl group or a group of either one of the following formulas: ##STR2## wherein R.sub.3 and R.sub.4, which may be the same or different, each represents a hydrogen atom or a lower alkyl group, or they are taken together to represent an alkylene chain to form, in combination with the adjacent nitrogen atom, a 3- to 7-membered cyclic amino group, --ZCOR.sub.5 (2) wherein Z represents --NH-- or --O-- and R.sub.5 represents an amino group, a mono(lower)alkylamino group, a di(lower)alkylamino group, a lower alkyloxy group or a lower alkyl group, ##STR3## wherein R.sub.6 represents a hydrogen atom or a lower alkyl group, --CH=N--R.sub.7 (4) wherein R.sub.7 represents a mono(lower)alkylamino group, a di(lower)alkylamino group or a lower alkyloxy group, or ##STR4## wherein R.sub.8, R.sub.9 and R.sub.10, which may be the same or different, each represents a hydrogen atom or a lower alkyl group, Y represents a hydrogen atom, a conventinal protecting group for an amino group or a group of either one of the following formulas: ##STR5## wherein R.sub.11 and R.sub.12, which may be the same or different, each represents a hydrogen atom or a lower alkyl group or ##STR6## wherein R.sub.6 is as defined above and n is an ingeter of 1 to 6, and a pharmacologically acceptable salt thereof, which is useful as an antimicrobial agent.

  该化合物的结构式为：##STR1## 其中R.sub.1是氢原子或较低的烷基基团，R.sub.2是氢原子或羧基的常规保护基团，R.sub.0是氢原子或羟基的常规保护基团，X是受保护或未受保护的氨基、羧基、较低的烷氧羰基、芳基(烷基)氧羰基、氰基、羟基、较低的烷氧基、较低的烷硫基、较低的烷基磺酰基或以下任一式的基团：##STR2## 其中R.sub.3和R.sub.4，可以相同也可以不同，每个代表氢原子或较低的烷基基团，或者它们一起代表一条烷基链，与相邻的氮原子结合形成3-至7-成员环氨基基团，--ZCOR.sub.5 (2) 其中Z代表--NH--或--O--，R.sub.5代表氨基、单(较低)烷基氨基、双(较低)烷基氨基、较低的烷氧基或较低的烷基，##STR3## 其中R.sub.6代表氢原子或较低的烷基基团，--CH=N--R.sub.7 (4) 其中R.sub.7代表单(较低)烷基氨基、双(较低)烷基氨基或较低的烷氧基，或者##STR4## 其中R.sub.8、R.sub.9和R.sub.10，可以相同也可以不同，每个代表氢原子或较低的烷基基团，Y代表氢原子、氨基的常规保护基团或以下任一式的基团：##STR5## 其中R.sub.11和R.sub.12，可以相同也可以不同，每个代表氢原子或较低的烷基基团或##STR6## 其中R.sub.6如上定义，n是1至6的整数，以及其药理学上可接受的盐，可用作抗微生物剂。
• 1- Methylcarbapenem derivatives
  申请人：Sankyo Company, Limited

  公开号：US06090802A1

  公开（公告）日：2000-07-18

  A 1-methylcarbapenem compound represented by the following formula (I): ##STR1## wherein R.sup.1 represents hydrogen or C.sub.1 -C.sub.4 alkyl; R.sup.2 represents hydrogen or an ester residue; and A represents a group of the formula (A1) ##STR2## wherein n is 0, 1 or 2, P is 0, 1 or 2, R.sup.3 is hydrogen or C.sub.1 -C.sub.4 alkyl and R.sup.4 is a group (Q2) ##STR3## wherein B is phenylene, phenylene(C.sub.1 -C.sub.3)alkyl, cyclohexylene, cyclohexylene(C.sub.1 -C.sub.3)alkyl or C.sub.1 -C.sub.5 alkylene, R.sup.7 is hydrogen or C.sub.1 -C.sub.4 alkyl, and R.sup.14 is a group --C(.dbd.NH)R.sup.8, wherein R.sup.8 is hydrogen or C.sub.1 -C.sub.4 alkyl or a group --NR.sup.9 R.sup.10, wherein R.sup.9 and R.sup.10 are the same or different and are hydrogen or C.sub.1 -C.sub.4 alkyl; or a pharmacologically acceptable salt thereof.

  一种由以下化学式（I）表示的1-甲基碳青霉烯类化合物：其中R.sup.1代表氢或C.sub.1 -C.sub.4烷基；R.sup.2代表氢或酯基；A代表以下化学式（A1）的基团：其中n为0、1或2，P为0、1或2，R.sup.3为氢或C.sub.1 -C.sub.4烷基，R.sup.4为基团（Q2）：其中B为苯基、苯基（C.sub.1 -C.sub.3）烷基、环己基、环己基（C.sub.1 -C.sub.3）烷基或C.sub.1 -C.sub.5烷基，R.sup.7为氢或C.sub.1 -C.sub.4烷基，R.sup.14为基团--C(.dbd.NH)R.sup.8，其中R.sup.8为氢或C.sub.1 -C.sub.4烷基或基团--NR.sup.9 R.sup.10，其中R.sup.9和R.sup.10相同或不同，为氢或C.sub.1 -C.sub.4烷基；或其药理学上可接受的盐。